Novartis says Alcon glaucoma treatment approved in EU
July 28, 2014 at 01:34 AM EDT
ZURICH, July 28 (Reuters) - Swiss pharmaceutical group Novartis said the European Commission has approved its eyecare unit Alcon's Simbrinza treatment for glaucoma, a chronic, sight-threatening eye disease.
